Systematic review assesses surgical interventions for trigeminal neuralgia in multiple sclerosis, highlighting personalized treatment pathways.
Trigeminal neuralgia affects approximately 3% of patients with multiple sclerosis - a significantly higher incidence than in the general population - and is recognised as a distinct clinical entity. Due to the challenges of treating these patients, we conducted this systematic review to provide an up-to-date assessment of surgical interventions for this debilitating condition whilst considering factors shaping personalised treatment pathways.
No takes yet. Share an insight, caveat, or question.
Kalyana et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: